Helmy Eltoukhy - 12 Mar 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Co-Chief Executive Officer, Director
Signature
/s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy
Issuer symbol
GH
Transactions as of
12 Mar 2025
Transactions value $
$0
Form type
4
Filing time
13 Mar 2025, 16:34:17 UTC
Previous filing
03 Jan 2025
Next filing
18 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Award $0 +19.3K $0.00 19.3K 12 Mar 2025 Common Stock 19.3K $0.00 Direct F1, F2
transaction GH Restricted Stock Units Award $0 +116K $0.00 116K 12 Mar 2025 Common Stock 116K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
F2 Not applicable for Restricted Stock Units.
F3 This represents a restricted stock unit award granted on March 12, 2025 that vests with respect to 33% of the shares on January 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.